From: Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort study
Factors
Multivariable (backward)
HR (95% CI)
P
Age
1.94 (0.92–1.98)
0.36
Gender
11.79 (0.49–6.57)
0.38
SVCS
11.48 (2.48–53.14)
0.002
PH (> 35mmHg)
5.47 (1.30-23.06)
0.02
Sclerostin over 218.18 pmol/L
2.70 (0.45–16.12)
0.28